S&P Futures
4,004.75 -2.50 (-0.06%) Dow Futures
32,644.00 +13.00 (+0.04%) Nasdaq Futures
12,762.75 -25.75 (-0.20%) Russell 2000 Futures
1,765.70 -1.60 (-0.09%) Crude Oil
73.28 +0.47 (+0.65%) Gold
1,952.50 -1.30 (-0.07%)
365917 (ONT)
| Previous Close | N/A |
| YTD Return | N/A |
| Expense Ratio (net) | N/A |
| Category | N/A |
| Last Cap Gain | N/A |
| Morningstar Rating | N/A |
| Morningstar Risk Rating | N/A |
| Sustainability Rating | N/A |
| Net Assets | N/A |
| Beta (5Y Monthly) | N/A |
| Yield | N/A |
| 5y Average Return | N/A |
| Holdings Turnover | N/A |
| Last Dividend | N/A |
| Average for Category | N/A |
| Inception Date | N/A |
- ACCESSWIRE
Genomics England Expands Nanopore Use in Cancer
Genomics England expands use of Oxford Nanopore sequencing in cancerOxford Nanopore technology will be used by Genomics England to investigate and validate at increasing scale the benefits of sequencing for improving patient care and advancing research to develop new treatments. Genomics England's "Long-Read Sequencing Programme" takes advantage of Oxford Nanopore's ability to sequence any-length fragments of DNA, including long and ultra-longOXFORD, UK / ACCESSWIRE / April 4, 2022 / Oxford Nano
- ACCESSWIRE
ONT Shows New High-Accuracy, High-Output Chemistry
Oxford Nanopore technology update: CTO Clive G Brown unveils latest sequencing chemistry with highest performance to date, Short Fragment Mode and latest methylation performance evaluationsClive G Brown, CTO, Oxford Nanopore Technologies, reviews some of the latest technology updates during a webinar today. Highlights include performance and base modification calling improvements, as well as updates on the recently-released Short Fragment Mode (SFM) and a new basecallerOXFORD, UK / ACCESSWIRE /
